Skip to main content

Shoppers Drug Mart on Queen St. at Portland St. in downtown Toronto.

Gloria Nieto/The Globe and Mail

Shoppers Drug Mart says it has submitted an application to be a distributor of medical marijuana.

A spokeswoman says in an e-mail that the drug store chain has applied to Health Canada to become a licensed medical marijuana producer – but only for the purpose of distributing the drug.

Tammy Smitham says Shoppers has "no intention" of producing cannabis. The application is an administrative requirement to be able to distribute the drug.

Story continues below advertisement

However, even if Shoppers' application is granted, the retailer won't be permitted to dispense the drug through its stores unless the government updates the regulations.

Under the current regime, patients are only permitted to buy medical marijuana directly from licensed producers, who send it by mail.

Smitham says Shoppers is hopeful that Ottawa will consider updating the rules to allow pharmacies to play a role in distributing medical marijuana.

"We believe that allowing medical marijuana to be dispensed through pharmacy would increase access, safety, quality and security for the thousands of Canadians who use the drug as part of their medication therapy," Smitham said in an e-mail.

Shoppers Drug Mart is owned by Loblaw Companies Ltd.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

If your comment doesn't appear immediately it has been sent to a member of our moderation team for review

Read our community guidelines here

Discussion loading…

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.